S.B. 2030 Summary

• Requires prescribers to offer naloxone prescriptions when dispensing opioids or benzodiazepines that meet certain criteria, including dosages of 90+ morphine milligram equivalents per day, concurrent opioid-benzodiazepine use within one year, or when patient has history of overdose or opioid use disorder.

• Mandates prescribers provide education on opioid overdose prevention and naloxone use to patients and at least one designated person, unless patient declines or received education within the past 24 months.

• Exempts prescribers from requirements when treating inmates, youth in state custody, hospitalized patients, terminally ill patients, and veterinary prescriptions.

• Requires pharmacists dispensing opioids to inform patients of overdose dangers and offer opioid antagonists annually when patient is concurrently prescribed benzodiazepines, carisoprodol, or tramadol, or when opioid dose is 90+ morphine milligram equivalents.

• Requires pharmacists to notify individuals receiving opioid antagonists of available generic and brand-name alternatives; exempts patients in hospice, palliative care, and veterans' community living centers.

• Effective date: January 1, 2050.